Figure 2
From: Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
Association of the VNTRs of SMYD3 with SMYD3 serum levels in HBV-related liver diseases. Comparison of the SMYD3 serum levels among healthy controls and patients with HBV-related liver diseases who carry different SMYD3 VNTR genotypes. CHB, chronic hepatitis B, LC, liver cirrhosis without HCC, HCC, hepatocellular carcinoma. (A) Among healthy controls and HBV patients, (B) among healthy controls and patient subgroups including CHB, LC and HCC patients, Box-plots illustrate medians with 25 and 75 percentiles with whiskers to 10 and 90 percentiles; P values were calculated by using Mann-Whitney-Wilcoxon test or Kruskal-Wallis test.
